PRECIGEN

Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

PRECIGEN

Social Links:

Twitter

Industry:

Biotechnology Life Science Medical Therapeutics

Founded:

1998-01-01

Address:

Germantown, Maryland, United States

Country:

United States

Website Url:

http://www.precigen.com

Total Employee:

251+

Status:

Active

Contact:

15409610734

Email Addresses:

[email protected]

Total Funding:

525.8 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving IPv6 Typekit Microsoft AddThis

Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

robert-shapiro_image

Robert Shapiro Member of the Board of Directors @ Precigen
Board_member
2011-11-01

cesar-alvarez_image

Cesar Alvarez Member of the Board of Directors @ Precigen
Board_member
2008-01-01

dean-j-mitchell_image

Dean J. Mitchell Board of Directors @ Precigen
Board_member
2009-03-01

not_available_image

Larry Horner Board of Directors @ Precigen
Board_member
2008-02-01

jeffrey-b-kindler_image

Jeffrey B. Kindler Board of Directors @ Precigen
Board_member
2011-11-01

Current Employees Featured

douglas-e-brough_image

Douglas E. Brough
Douglas E. Brough Senior Vice President & Head of Research @ Precigen
Senior Vice President & Head of Research
2020-07-01

thomas-d-reed_image

Thomas D. Reed
Thomas D. Reed Founder & Chief Science Officer, Board of Directors @ Precigen
Founder & Chief Science Officer, Board of Directors
1998-01-01

hadyn-parry_image

Hadyn Parry
Hadyn Parry Vice President @ Precigen
Vice President
2018-05-01

jack-bobo_image

Jack Bobo
Jack Bobo Chief Communications Officer @ Precigen
Chief Communications Officer
2015-07-01

peter-seufer-wasserthal_image

Peter Seufer-Wasserthal
Peter Seufer-Wasserthal Vice President, Business Development, Europe and Asia @ Precigen
Vice President, Business Development, Europe and Asia

not_available_image

Darryl Webster
Darryl Webster Senior Vice President, Intellectual Property @ Precigen
Senior Vice President, Intellectual Property

krish-s-krishnan_image

Krish S. Krishnan
Krish S. Krishnan Chief Operating Officer @ Precigen
Chief Operating Officer

randal-j-kirk_image

Randal J. Kirk
Randal J. Kirk CEO and Chairman @ Precigen
CEO and Chairman
2008-02-01

samuel-broder_image

Samuel Broder
Samuel Broder Chairman, Health Sector @ Precigen
Chairman, Health Sector
2012-01-01

not_available_image

Marcelo Quiroga
Marcelo Quiroga Chief Operating Officer @ Precigen
Chief Operating Officer

Founder

thomas-d-reed_image

Thomas D. Reed

Stock Details

Company's stock symbol is NASDAQ:PGEN

Acquisitions List

Date	Company	Article	Price
2017-01-24	GenVec	GenVec acquired by Precigen	N/A
2016-02-25	EnviroFlight	EnviroFlight acquired by Precigen	N/A
2015-08-10	Oxitec	Oxitec acquired by Precigen	160 M USD
2015-02-13	ActoGeniX	ActoGeniX acquired by Precigen	60 M USD
2013-12-20	Medistem	Medistem acquired by Precigen	N/A
2011-10-24	Immunologix	Immunologix acquired by Precigen	N/A
2011-02-02	Agarigen, Inc	Agarigen, Inc acquired by Precigen	N/A

Investors List

randal-j-kirk_image

Investments List

Date	Company	Article	Money raised
2014-12-02	Histogenics	Precigen investment in Post-IPO Equity - Histogenics	70 M USD

Key Employee Changes

Date	New article
2021-10-12	Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer

Official Site Inspections

http://www.precigen.com Semrush global rank: 1.95 M Semrush visits lastest month: 11.04 K

Host Informations
Whois Informations

Loading ...